Acclaimed soul vocalist D’Angelo died on October 14 at 51 years old after a private battle with pancreatic cancer.
“The brilliant light of our household has faded away for us in the present world,” his family confirmed. “After a lengthy and courageous struggle with the disease, we are deeply saddened to declare that D’Angelo, recognized by his fans around the globe as D’Angelo, has been called home.”
D’Angelo left an indelible mark on music with his pioneering neo-soul sound and partnerships with renowned musicians.
He released his first record, “Brown Sugar,” in 1995 to immediate acclaim. The record achieved No. 4 on the R&B charts, went platinum later that year, and received multiple Grammy nominations.
However, it was his second album, “Voodoo,” in 2000 that propelled his music career into the stratosphere. The album premiered at No. 1 on both Billboard’s Top R&B Albums chart and the main album chart. He won two Grammys: Best R&B Album and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”
The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a sex symbol, albeit a reluctant one, in the public consciousness. The intimate portrayal featured the singer, notably stripped down to his waist, performing directly into the lens.
D’Angelo stepped back from the spotlight after putting out Voodoo and publicly struggled with drugs and alcohol. In 2005, he was involved in a serious car crash that left him in critical condition.
Over ten years later, his last record, “Black Messiah” (2014), reaffirmed his enduring appeal with another top chart entry on the soul music rankings and a award for Best R&B Album.
Again, in his own enigmatic fashion, D’Angelo had limited public appearances in the subsequent period.
The singer was announced as a top act for the 2025 music event, but his performance was called off, due to an “unexpected health issue.”
Although information is limited about D’Angelo’s well-being in the months leading up to his passing, he had apparently been hospitalized for months and in hospice for a fortnight.
D’Angelo’s demise is a stark reminder of the harmful impact of pancreatic malignancy, one of the most deadly and hardest to prevent forms of the disease, on a brilliant talent whose existence was ended too soon.
“We are grieved that he can only leave cherished moments with his loved ones, but we are eternally grateful for the legacy of deeply emotional songs he leaves behind,” his kin expressed.
Pancreatic malignancy impacts the pancreas, a small organ that produces the hormone insulin and plays an essential role in breaking down food, among additional roles. The position and dimensions of the organ in the human system make it more difficult to detect cancer.
Even though pancreatic cancer makes up only about 3% of malignancy cases each year in the United States, it is causes seven percent of cancer deaths.
Nearly 70,000 individuals will be diagnosed with pancreatic cancer and roughly fifty-two thousand will succumb to the illness in the year 2025.
“Pancreatic cancer is one of the most lethal diseases, with an fast-growing mass and dismal outcomes. We have few and ineffective therapies, and a smaller window to make a significant difference on the well-being of patients,” noted a medical oncologist.
Since this disease seldom produces early symptoms, it’s often diagnosed only once the disease is advanced. Even when a individual has symptoms they are usually vague and may be confused with a several common illnesses.
“Currently, there is no good way to identify this malignancy in the early stages, except for listening to your body and consulting your physician if there are new or unusual symptoms,” said a medical director.
Common symptoms of pancreatic cancer include:
At age 51, D’Angelo’s death is an exception, as pancreatic cancer is typically found in individuals in the 65 to 75 age bracket. However, many cancers, such as this type, have become more common in younger people.
“Pancreatic cancer diagnosed before the age of 50 is deemed rare, yet concerningly, clinicians are beginning to see a rising count of younger patients suffering from this condition,” commented a specialist.
Without effective screening tools for this malignancy, experts stressed the significance of knowing your relatives’ health background. Some risk factors, such as smoking and obesity also have an influence in the onset of pancreatic cancer.
Black individuals have the greatest occurrence of this malignancy in the U.S. and are most likely to be diagnosed with untreatable disease.
“The first step toward lowering one’s chance of pancreatic cancer is understanding personal risk factors. Individuals should examine their genetic background, hereditary factors, and medical conditions, such as blood sugar disease, long-term pancreas inflammation, or obesity that may increase their vulnerability,” advised a specialist.
Hereditary risk factors are associated with as much as ten percent of all pancreatic cancer instances. If a relative in your family has had this disease, you may want to consider genetic testing.
“For individuals with a relative’s background of this condition or those carrying elevated risk genetic mutations, checking may involve advanced imaging such as magnetic resonance imaging (MRI) or internal ultrasound to find initial alterations in the pancreas,” he clarified.
For those looking to lower their chance, habit adjustments may have an effect. The best action you can take to reduce your susceptibility of this disease is to stop tobacco use, and if you are a non-smoker, stay away altogether.
Excessive alcohol consumption is linked to pancreas inflammation, a contributing element for this malignancy, so reducing or abstaining from alcohol may help reduce your risk.
Managing your weight or losing weight may also help reduce your risk. People with obesity are twenty percent more prone to get this disease. This malignancy also is more frequent in people with diabetes, and weight loss can also lower the chance of type 2 diabetes.
Despite this disease’s grim outlook, there is reason for optimism.
“We are making progress with therapies and more recent combination chemotherapy. There are emerging precision medicines that already are showing results,” remarked a expert.
For numerous people, however, education about this rare but {dev
A seasoned automotive journalist with a passion for classic cars and modern innovations, sharing insights and stories from the road.